VistaGen, WARF Sign License Agreement for Human Embryonic Stem Cell Technology
Thursday, December 18, 2008 - 18:28
in Biology & Nature
VistaGen Therapeutics and the Wisconsin Alumni Research Foundation (WARF) have signed a license for human embryonic stem cell patents for the development and commercialization of stem cell-based research tools.